Published in Arch Ophthalmol on June 01, 2007
What stroke symptoms tell us: association of risk factors and individual stroke symptoms in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. J Stroke Cerebrovasc Dis (2012) 0.82
Magnetic resonance imaging changes associated with transient homonymous hemianopia in patients with nonketotic hyperglycemia. Arch Ophthalmol (2008) 0.76
Visual hallucination of coloured numbers secondary to hyperglycaemia. BMJ Case Rep (2011) 0.75
Homonymous hemianopia: challenges and solutions. Clin Ophthalmol (2014) 0.75
Advances in methods and algorithms in a modern quantum chemistry program package. Phys Chem Chem Phys (2006) 6.51
Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial. JAMA (2011) 6.39
Generalized born model with a simple smoothing function. J Comput Chem (2003) 4.36
Performance comparison of generalized born and Poisson methods in the calculation of electrostatic solvation energies for protein structures. J Comput Chem (2004) 3.83
Procedural variation in the performance of primary percutaneous coronary intervention for ST-elevation myocardial infarction: a SCAI-based survey study of US interventional cardiologists. Catheter Cardiovasc Interv (2013) 2.02
Perioperative visual loss in ocular and nonocular surgery. Clin Ophthalmol (2010) 1.92
Unprotected left main revascularization in patients with acute coronary syndromes. Eur Heart J (2009) 1.66
Amantadine-associated corneal edema potentially irreversible even after cessation of the medication. Ophthalmology (2008) 1.63
Clinical characteristics in 53 patients with cat scratch optic neuropathy. Ophthalmology (2011) 1.62
Late and very late stent thrombosis following drug-eluting stent implantation in unprotected left main coronary artery: a multicentre registry. Eur Heart J (2008) 1.58
Recurrent visual field defect and ischemic optic neuropathy associated with tadalafil rechallenge. Arch Ophthalmol (2005) 1.58
Ocular ethambutol toxicity. Mayo Clin Proc (2003) 1.57
Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma. Am J Ophthalmol (2007) 1.56
Percutaneous left ventricular assist device: "TandemHeart" for high-risk coronary intervention. Catheter Cardiovasc Interv (2005) 1.49
Comparison of coronary artery bypass surgery and percutaneous drug-eluting stent implantation for treatment of left main coronary artery stenosis. JACC Cardiovasc Interv (2008) 1.48
False-negative apraclonidine testing in acute Horner syndrome. Can J Ophthalmol (2009) 1.43
Preprocedural white blood cell count as a predictor of death and major adverse cardiac events in patients undergoing percutaneous coronary intervention with drug-eluting stents. J Invasive Cardiol (2009) 1.40
Comparison of drug-eluting stents with bare metal stents in unselected patients with acute myocardial infarction. Catheter Cardiovasc Interv (2007) 1.40
Re-examination of the antithrombotic regimen in the STEMI-RADIAL trial. J Am Coll Cardiol (2014) 1.39
Saphenous vein graft intervention: status report 2014. J Invasive Cardiol (2014) 1.39
Percutaneous intervention of left main coronary artery compression by pulmonary artery aneurysm. Catheter Cardiovasc Interv (2010) 1.39
Fibromuscular dysplasia of the left anterior descending coronary artery. JACC Cardiovasc Interv (2012) 1.38
Isolated third, fourth, and sixth cranial nerve palsies from presumed microvascular versus other causes: a prospective study. Ophthalmology (2013) 1.36
Drug-eluting stent fracture: incidence, contributing factors, and clinical implications. Catheter Cardiovasc Interv (2010) 1.32
Comparison and temporal trends of three groups with cryptococcosis: HIV-infected, solid organ transplant, and HIV-negative/non-transplant. PLoS One (2012) 1.30
Ebola virus genome plasticity as a marker of its passaging history: a comparison of in vitro passaging to non-human primate infection. PLoS One (2012) 1.28
The latent structure of attention-deficit/hyperactivity disorder in a clinic-referred sample. Neuropsychology (2007) 1.14
Computerized neuropsychological assessment devices: joint position paper of the American Academy of Clinical Neuropsychology and the National Academy of Neuropsychology. Clin Neuropsychol (2012) 1.08
Pegylated interferon alpha-associated optic neuropathy. J Neuroophthalmol (2010) 1.06
Extensive antibody cross-reactivity among infectious gram-negative bacteria revealed by proteome microarray analysis. Mol Cell Proteomics (2008) 1.05
Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS. J Drug Target (2010) 0.99
Optic neuropathy in vitamin B12 deficiency. Eur J Intern Med (2005) 0.97
Magnesium as a neuroprotectant in cardiac surgery: a randomized clinical trial. J Thorac Cardiovasc Surg (2006) 0.96
Transplant coronary artery disease. JACC Cardiovasc Interv (2010) 0.96
Computerized neuropsychological assessment devices: joint position paper of the American Academy of Clinical Neuropsychology and the National Academy of Neuropsychology. Arch Clin Neuropsychol (2012) 0.95
Improvement in visual fields in a patient with melanoma-associated retinopathy treated with intravenous immunoglobulin. J Neuroophthalmol (2008) 0.94
Calculation of protein heat capacity from replica-exchange molecular dynamics simulations with different implicit solvent models. J Phys Chem B (2008) 0.94
Evaluating the contributions of state-of-the-art assessment techniques to predicting memory outcome after unilateral anterior temporal lobectomy. Epilepsia (2006) 0.93
Posterior vitreous detachment in AION. Ophthalmology (2009) 0.90
Experimental and clinical evidence for brimonidine as an optic nerve and retinal neuroprotective agent: an evidence-based review. Arch Ophthalmol (2009) 0.90
Identification of small-molecule inhibitors of Yersinia pestis Type III secretion system YscN ATPase. PLoS One (2011) 0.89
Patent foramen ovale: clinical manifestations and treatment. Rev Cardiovasc Med (2008) 0.89
Occlusive vasculitis in a patient with concomitant West Nile virus infection. Am J Ophthalmol (2003) 0.89
Sampling of near-native protein conformations during protein structure refinement using a coarse-grained model, normal modes, and molecular dynamics simulations. Proteins (2008) 0.87
Comparison between self-guided Langevin dynamics and molecular dynamics simulations for structure refinement of protein loop conformations. J Comput Chem (2011) 0.87
FIEFDom: a transparent domain boundary recognition system using a fuzzy mean operator. Nucleic Acids Res (2008) 0.87
Structure refinement of protein model decoys requires accurate side-chain placement. Proteins (2012) 0.87
Bimolecular Complementation to Visualize Filovirus VP40-Host Complexes in Live Mammalian Cells: Toward the Identification of Budding Inhibitors. Adv Virol (2011) 0.86
Approaches to antifungal therapies and their effectiveness among patients with cryptococcosis. Antimicrob Agents Chemother (2013) 0.86
WMS-III performance in epilepsy patients following temporal lobectomy. J Int Neuropsychol Soc (2004) 0.86
Can hygroscopic expansion compensate polymerization shrinkage? Part I. Deformation of restored teeth. Dent Mater (2010) 0.86
Comatic aberration as a cause of monocular diplopia. J Cataract Refract Surg (2006) 0.85
Increasing the reliability of ipsative interpretations in neuropsychology: a comparison of reliable components analysis and other factor analytic methods. J Int Neuropsychol Soc (2004) 0.85
Ocular and orbital pain for the headache specialist. Curr Neurol Neurosci Rep (2011) 0.85
Another case of leber hereditary optic neuropathy in an octogenarian. J Neuroophthalmol (2009) 0.84
The Family Pictures subtest of the WMS-III: relationship to verbal and visual memory following temporal lobectomy for intractable epilepsy. J Clin Exp Neuropsychol (2009) 0.84
Bilateral retinal occlusion progressing to long-lasting blindness in severe preeclampsia. Obstet Gynecol (2002) 0.84
A host-oriented inhibitor of Junin Argentine hemorrhagic fever virus egress. J Virol (2014) 0.83
Treatment of vision loss in giant cell arteritis. Curr Treat Options Neurol (2012) 0.83
Prevalence of optic nerve edema in patients on peripheral hemodialysis. Ophthalmology (2007) 0.83
Effects of elevated thyroid hormone on adult rabbit extraocular muscles. Invest Ophthalmol Vis Sci (2009) 0.83
Profile of Xeomin® (incobotulinumtoxinA) for the treatment of blepharospasm. Clin Ophthalmol (2011) 0.82
Update on thyroid eye disease and management. Clin Ophthalmol (2009) 0.82
Retinal nerve fiber layer thickness using spectral-domain optical coherence tomography in patients with no light perception secondary to optic atrophy. J Neuroophthalmol (2013) 0.82
Normal exophthalmometry measurements in a United States pediatric population. Ophthal Plast Reconstr Surg (2012) 0.82
Incidence of ocular injury in visually asymptomatic orbital fractures. Ophthal Plast Reconstr Surg (2009) 0.82
Atypical Leber Hereditary Optic Neuropathy: 18 Year Interval Between Eyes. J Neuroophthalmol (2016) 0.82
Indications for neuropsychological assessment. Cleve Clin J Med (2003) 0.81
Excision of periorbital hemangiomas to correct visual abnormalities. Arch Facial Plast Surg (2011) 0.81
Stent thrombosis with drug-eluting stents: a re-examination of the evidence. Catheter Cardiovasc Interv (2007) 0.81
Arthroscopic versus open ankle arthrodesis: a retrospective cost analysis. J Foot Ankle Surg (2010) 0.81
Gender-related differences of diabetic patients undergoing percutaneous coronary intervention with drug-eluting stents: a real-life multicenter experience. Int J Cardiol (2012) 0.80
Percutaneous coronary intervention in nonagenarian: a meta-analysis of observational studies. J Cardiovasc Med (Hagerstown) (2013) 0.80
Lash ptosis in congenital and acquired blepharoptosis. Arch Ophthalmol (2007) 0.80
Genomic variability of monkeypox virus among humans, Democratic Republic of the Congo. Emerg Infect Dis (2014) 0.80
Modulating neuromuscular junction density changes in botulinum toxin-treated orbicularis oculi muscle. Invest Ophthalmol Vis Sci (2011) 0.80
The latent structure of cognitive symptom exaggeration on the Victoria Symptom Validity Test. Arch Clin Neuropsychol (2007) 0.80
Is there treatment for traumatic optic neuropathy? Curr Opin Ophthalmol (2015) 0.79
Revised Cardiac Risk Index (RCRI) is a useful tool for evaluation of perioperative cardiac morbidity in kidney transplant recipients. Transplantation (2013) 0.79
Patients' perceptions of memory functioning before and after surgical intervention to treat medically refractory epilepsy. Epilepsia (2004) 0.79
The woman who needed a pet. Surv Ophthalmol (2006) 0.79
APOE epsilon4 is associated with postictal confusion in patients with medically refractory temporal lobe epilepsy. Epilepsy Res (2008) 0.79
Can computationally designed protein sequences improve secondary structure prediction? Protein Eng Des Sel (2011) 0.78
Elevated plasma fibrinogen rather than residual platelet reactivity after clopidogrel pre-treatment is associated with an increased ischemic risk during elective percutaneous coronary intervention. J Am Coll Cardiol (2013) 0.78
Characterization and multiparameter analysis of visual adverse events in irofulven single-agent phase I and II trials. Clin Cancer Res (2004) 0.78
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents 70 restenotic cases from a cohort of 718 patients: FAILS (Failure in Left Main Study). J Am Coll Cardiol (2009) 0.78
Nonarteritic anterior ischemic optic neuropathy and 'visual field defects' following vitrectomy: could they be related? Graefes Arch Clin Exp Ophthalmol (2006) 0.78
Uveitis associated with West Nile virus infection. Arch Ophthalmol (2003) 0.78
Coronary perforation after percutaneous coronary intervention successfully treated with local thrombin injection. J Invasive Cardiol (2006) 0.78
The role of conjunctival biopsy in the diagnosis of Wegener's granulomatosis: a case report. Can J Ophthalmol (2002) 0.78
Effect of patient positioning on cerebrospinal fluid opening pressure. J Neuroophthalmol (2014) 0.77
Interaction of the disordered Yersinia effector protein YopE with its cognate chaperone SycE. Biochemistry (2009) 0.77
A multicenter retrospective review of outcomes for arthrodesis, hemi-metallic joint implant, and resectional arthroplasty in the surgical treatment of end-stage hallux rigidus. J Foot Ankle Surg (2011) 0.77
Application of replica exchange umbrella sampling to protein structure refinement of nontemplate models. J Comput Chem (2013) 0.77
Relationship between presurgical memory performance on the Wechsler Memory Scale-III and memory change following temporal resection for treatment of intractable epilepsy. Epilepsy Behav (2008) 0.77
Can't hear, can't see, and too sore to play. Surv Ophthalmol (2010) 0.77
Patients with homonymous hemianopia become visually qualified to drive using novel monocular sector prisms. J Neuroophthalmol (2014) 0.77
Psychometric adequacy and comparability of the short and full forms of the Personality Assessment Inventory. Psychol Assess (2006) 0.76
Effect of diabetes mellitus on giant cell arteritis. J Neuroophthalmol (2015) 0.76
Comparison of pain scores with 30-gauge and 32-gauge needles for periocular botulinum toxin type a injections. Ophthal Plast Reconstr Surg (2009) 0.76